CSIMarket
Cardiff Oncology inc   (CRDF)
Other Ticker:  
 
 

Cardiff Oncology Inc 's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



CRDF Annual Income from Cont. Operations Growth

2022
2021
2020
2019
2018
Y / Y Annual Income from Cont. Operations Change - - - - -
Annual Income from Cont. Operations (in millions $) $-38.70 $-28.29 $-22.57 $-16.68 $-19.23


Annual Income from Cont. Operations Growth Comment
Cardiff Oncology Inc realized loss from Cont. Operations.

Cardiff Oncology Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2022 Annual Income from Cont. Operations
Sinovac Biotech Ltd -99.39 %$ 88.131  millions
The Cooper Companies Inc -86.90 %$ 385.800  millions
Royalty Pharma Plc -81.46 %$ 230.064  millions
Incyte Corporation -64.09 %$ 340.660  millions
Align Technology inc -53.17 %$ 361.573  millions
Encompass Health Corporation -31.99 %$ 352.000  millions
Fulgent Genetics Inc -71.97 %$ 141.923  millions
Teleflex Incorporated -25.19 %$ 362.916  millions
Halozyme Therapeutics Inc -49.81 %$ 202.129  millions
Zimmer Biomet Holdings Inc -27.58 %$ 291.200  millions
Steris Plc -38.80 %$ 242.870  millions
Alcon inc -10.90 %$ 335.000  millions
Innoviva Inc -40.28 %$ 220.262  millions
Community Health Systems Inc -51.36 %$ 179.000  millions
Uniqure N v